InvestorsHub Logo
Followers 8
Posts 2018
Boards Moderated 0
Alias Born 07/19/2006

Re: wcopeland post# 843

Friday, 04/21/2017 8:39:40 PM

Friday, April 21, 2017 8:39:40 PM

Post# of 2099
3. May be most important. Is there any difference in survival after progression? The concept of tumor growth kinetics/survival after progression is a fascinating one. I would be especially interested in rates of progression after patients have failed VB-111 after several dosages; do they progress in the same manner as typical avastin failure patients? Dror seems to allude to a difference in this at last KOL event in May of '16.

Here is an excellent scholarly introduction to this theme.... check out the section on tumor growth kinetics and interferon effects on renal cell ca....

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708548/#CIT0042
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News